desipramine has been researched along with 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirose, N; Kamei, J; Murasawa, H; Nakatani, A; Saitoh, A; Takahashi, K; Tatsumi, Y; Yamada, M; Yamaguchi, K | 1 |
1 other study(ies) available for desipramine and 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide
| Article | Year |
|---|---|
Antidepressant-like effects of the delta-opioid receptor agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in an olfactory bulbectomized rat model.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Behavior, Animal; Benzamides; Brain; Depression; Desipramine; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Maze Learning; Olfactory Bulb; Piperazines; Rats; Rats, Wistar; Serotonin; Time Factors; Tryptophan Hydroxylase | 2008 |